Using silver poly (acrylate) matrix (Haemoblock) in children with lymphatic malformations

Lymphatic malformations (LM) are a congenital malformation of lymphatic vessels. There exist large, small and mixed cystic LMs. Up to the present day, the causes of LM remain the subject of scientific research. Special sclerosing agents such as Doxycycline, Bleocyne, Picibanil (OK-432) and other dru...

Full description

Bibliographic Details
Main Authors: D.A. Safin, D.V. Romanov
Format: Article
Language:English
Published: Elsevier 2019-07-01
Series:Journal of Pediatric Surgery Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213576619300673
id doaj-1106abbfa4664bb28845603afb1611fa
record_format Article
spelling doaj-1106abbfa4664bb28845603afb1611fa2020-11-24T23:56:09ZengElsevierJournal of Pediatric Surgery Case Reports2213-57662019-07-0146Using silver poly (acrylate) matrix (Haemoblock) in children with lymphatic malformationsD.A. Safin0D.V. Romanov1Corresponding author.; Pediatric Surgeon, International Center of Vascular Anomaly, Korovinskoye Highway, House 9, Building 2, 127486, Moscow, RussiaPediatric Surgeon, International Center of Vascular Anomaly, Korovinskoye Highway, House 9, Building 2, 127486, Moscow, RussiaLymphatic malformations (LM) are a congenital malformation of lymphatic vessels. There exist large, small and mixed cystic LMs. Up to the present day, the causes of LM remain the subject of scientific research. Special sclerosing agents such as Doxycycline, Bleocyne, Picibanil (OK-432) and other drugs are used for sclerosing of LM. Due to the special characteristics of the impact of each drug on the endothelium, during the early post-surgical period there occur various undesirable effects (swelling, pain conditions, toxic effects, allergies, etc.), moreover, the effectiveness of the used sclerosing agents is not always sufficient to obtain a good clinical effect. The goal of our work is to evaluate the use of the Haemoblock™ sclerotherapy in children with various forms of lymphatic malformations. We carried out a retrospective analysis of the use of the silver poly (acrylate) matrix (Haemoblock™) for sclerotherapy (off-label protocol) of various forms of LM in children who underwent treatment at the Center for Vascular Pathology (Moscow) during the period from 2016 to 2018. After the conducted surgery - sclerotherapy with the Haemoblock™ in children with various LMs, we obtained the following results: excellent and good - in 6 cases, satisfactory - in 2 cases, no negative result was obtained. In the Center for Vascular Pathology (Moscow) in 2016–2018, there was conducted a treatment of 8 children with LM of various types and localization. During the early post-surgical stages (1–3 h after surgery), 4 children showed severe pain syndrome, which stopped on its own without prescription of drug-induced pain killers. 12–24 h after sclerotherapy, 6 children also showed an increase in swelling in the area of the surgery. The swelling persisted for 3–6 days, and stopped on its own. Considering the positive results of treatment, further multi center study of the use of the Haemoblock™ is needed for the purpose of the LM sclerotherapy in children. Keywords: Lymphatic malformation, Sclerotherapy, Haemoblock, Childrenhttp://www.sciencedirect.com/science/article/pii/S2213576619300673
collection DOAJ
language English
format Article
sources DOAJ
author D.A. Safin
D.V. Romanov
spellingShingle D.A. Safin
D.V. Romanov
Using silver poly (acrylate) matrix (Haemoblock) in children with lymphatic malformations
Journal of Pediatric Surgery Case Reports
author_facet D.A. Safin
D.V. Romanov
author_sort D.A. Safin
title Using silver poly (acrylate) matrix (Haemoblock) in children with lymphatic malformations
title_short Using silver poly (acrylate) matrix (Haemoblock) in children with lymphatic malformations
title_full Using silver poly (acrylate) matrix (Haemoblock) in children with lymphatic malformations
title_fullStr Using silver poly (acrylate) matrix (Haemoblock) in children with lymphatic malformations
title_full_unstemmed Using silver poly (acrylate) matrix (Haemoblock) in children with lymphatic malformations
title_sort using silver poly (acrylate) matrix (haemoblock) in children with lymphatic malformations
publisher Elsevier
series Journal of Pediatric Surgery Case Reports
issn 2213-5766
publishDate 2019-07-01
description Lymphatic malformations (LM) are a congenital malformation of lymphatic vessels. There exist large, small and mixed cystic LMs. Up to the present day, the causes of LM remain the subject of scientific research. Special sclerosing agents such as Doxycycline, Bleocyne, Picibanil (OK-432) and other drugs are used for sclerosing of LM. Due to the special characteristics of the impact of each drug on the endothelium, during the early post-surgical period there occur various undesirable effects (swelling, pain conditions, toxic effects, allergies, etc.), moreover, the effectiveness of the used sclerosing agents is not always sufficient to obtain a good clinical effect. The goal of our work is to evaluate the use of the Haemoblock™ sclerotherapy in children with various forms of lymphatic malformations. We carried out a retrospective analysis of the use of the silver poly (acrylate) matrix (Haemoblock™) for sclerotherapy (off-label protocol) of various forms of LM in children who underwent treatment at the Center for Vascular Pathology (Moscow) during the period from 2016 to 2018. After the conducted surgery - sclerotherapy with the Haemoblock™ in children with various LMs, we obtained the following results: excellent and good - in 6 cases, satisfactory - in 2 cases, no negative result was obtained. In the Center for Vascular Pathology (Moscow) in 2016–2018, there was conducted a treatment of 8 children with LM of various types and localization. During the early post-surgical stages (1–3 h after surgery), 4 children showed severe pain syndrome, which stopped on its own without prescription of drug-induced pain killers. 12–24 h after sclerotherapy, 6 children also showed an increase in swelling in the area of the surgery. The swelling persisted for 3–6 days, and stopped on its own. Considering the positive results of treatment, further multi center study of the use of the Haemoblock™ is needed for the purpose of the LM sclerotherapy in children. Keywords: Lymphatic malformation, Sclerotherapy, Haemoblock, Children
url http://www.sciencedirect.com/science/article/pii/S2213576619300673
work_keys_str_mv AT dasafin usingsilverpolyacrylatematrixhaemoblockinchildrenwithlymphaticmalformations
AT dvromanov usingsilverpolyacrylatematrixhaemoblockinchildrenwithlymphaticmalformations
_version_ 1725459356643753984